We are live on
!
Find out more
IC
Icahn Carl Portfolio holdings
AUM
$8.55B
1-Year Est. Return
29.29%
This Fund
S&P 500
This Quarter
Est. Return
-8.59%
1 Year Est. Return
+29.29%
3 Year Est. Return
-52.41%
5 Year Est. Return
-44.99%
10 Year Est. Return
-2.67%
AUM
$20.3B
AUM Growth
-$1.21B
(-5.6%)
Cap. Flow
+$941M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
87.22%
Holding
23
New
2
Increased
3
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$784M |
| 2 |
HTZ
Hertz Global Holdings, Inc.
HTZ
|
+$559M |
| 3 |
Icahn Enterprises
IEP
|
+$333M |
| 4 |
American International
AIG
|
+$67.5M |
| 5 |
Xerox
XRX
|
+$66.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$568M |
| 2 |
PayPal
PYPL
|
+$150M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$144M |
| 4 |
ENZN
ENZON PHARMACEUTICALS INC
ENZN
|
+$2.77M |
| 5 |
SSE
SEVENTY SEVEN ENERGY INC COM
SSE
|
+$2.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 47.43% |
| 2 | Financials | 18.01% |
| 3 | Industrials | 9.38% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Materials | 5.71% |
Similar funds
NB
ACM
PCM
AV
GRQ
DM
PCIA
FT
Icahn Carl's Q2 2016 Portfolio in Review
As of Q2 2016, Icahn Carl held 23 positions worth $20.3B, down 5.6% from $21.5B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Icahn Carl deployed $941M of net new capital in Q2 2016, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Allergan plc: 3,400,000 shares worth $786M.
By sector, the portfolio is most concentrated in Energy at 47% of assets, down from 51% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Herc Holdings, an estimated $568M trimmed.
- Icahn Carl's largest Q2 2016 buy was Allergan plc: 3,400,000 shares worth $786M.
- Icahn Carl added most to Icahn Enterprises in Q2 2016, an estimated $333M increase.
- Icahn Carl's biggest Q2 2016 reduction was Herc Holdings, cutting an estimated $568M.
- Icahn Carl fully exited ENZON PHARMACEUTICALS INC in Q2 2016, selling an estimated $2.77M.
- Icahn Carl's ten largest holdings make up 87% of its $20.3B portfolio in Q2 2016.
- Icahn Carl opened 2 new positions and closed 2 in Q2 2016.
- Icahn Carl's portfolio value fell 5.6% quarter-over-quarter to $20.3B.
Based on Icahn Carl's 13F filing for Q2 2016, filed 15 Aug 2016.